A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen - Related Studies

A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen

This study is currently recruiting participants.

Study NCT00623831. Last updated on August 7, 2008. Information provided by Ludwig Institute for Cancer Research

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Melanoma
		Sarcoma
		Head and Neck Cancer
		Transitional Cell Carcinoma
		Prostate Cancer

2	Additional conditions recognized in this trial
		Carcinoma
		Carcinoma, Transitional Cell
		Gastrointestinal Stromal Tumors
		Head and Neck Neoplasms
		Prostatic Neoplasms

3	More general conditions related to this trial
		Digestive System Diseases
		Digestive System Neoplasms
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Genital Diseases, Male
		Genital Neoplasms, Male
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Glandular and Epithelial
		Neoplasms, Nerve Tissue
		Neuroectodermal Tumors
		Neuroendocrine Tumors
		Nevi and Melanomas
		Prostatic Diseases
		Urogenital Neoplasms

4	Interventions listed in this trial
		Mixed Bacterial Vaccine (MBV)

5	Sponsors listed in this trial
		Ludwig Institute for Cancer Research